Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial

被引：0
|
作者：
Geetha, Duvuru [1 ]
Dua, Anisha [2 ]
Yue, Huibin [3 ]
Salvarani, Carlo [4 ]
Jayne, David [5 ]
Merkel, Peter [6 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Northwestern Univ, Chicago, IL USA
[3] Amgen Inc, Thousand Oaks, CA USA
[4] Azienda USL IRCCS Reggio Emilia, Reggio Emilia, Italy
[5] Univ Cambridge, Cambridge, England
[6] Univ Penn, Philadelphia, PA 19104 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0685
引用
收藏
页码：1366 / 1367
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Springer, Jason
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (02) : 223 - 232
  • [2] EFFICACY AND SAFETY OF AVACOPAN IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS RECEIVING RITUXIMAB IN THE ADVOCATE TRIAL
    Geetha, D.
    Dua, A.
    Yue, H.
    Salvarani, C.
    Jayne, D.
    Merkel, P. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 338 - 339
  • [3] A RANDOMIZED PHASE 3 TRIAL EVALUATING THE SAFETY AND EFFICACY OF AVACOPAN IN PATIENTS WITH NEW OR RELAPSING ANCA-ASSOCIATED VASCULITIS
    Merkel, Peter
    Jayne, David
    Harigai, Masayoshi
    Schall, Thomas
    Bekker, Pirow
    Potarca, Antonia
    Hillson, Jan
    RHEUMATOLOGY, 2019, 58
  • [4] Avacopan for Patients with ANCA-associated Vasculitis
    Rauen, Thomas
    Kraemer, Stefan
    Floege, Juergen
    NEPHROLOGIE, 2022, 17 (02): : 117 - 118
  • [5] Safety and Efficacy of Avacopan in Patients 65 Years and Older with ANCA-Associated Vasculitis
    Jayne, David
    Geetha, Duvuru
    Pagnoux, Christian
    Sattui, Sebastian
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1367 - 1369
  • [6] Safety and Efficacy of Avacopan in Patients 65 Years and Older with ANCA-Associated Vasculitis
    Rauen, Thomas
    Geetha, Duvuru
    Pagnoux, Christian
    Sattui, Sebastian E.
    Merkel, Peter A.
    Jayne, David R.
    INNERE MEDIZIN, 2024, 65 : S87 - S88
  • [7] Integrated Safety of Avacopan in ANCA-Associated Vasculitis
    Jayne, David R.
    Bekker, Pirow
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 794 - 795
  • [8] The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review
    Habibi, Mohammad Amin
    Alesaeidi, Samira
    Zahedi, Mohadeseh
    Rahmani, Samin Hakimi
    Piri, Seyed Mohammad
    Tavakolpour, Soheil
    BIOLOGY-BASEL, 2022, 11 (12):
  • [9] Avacopan for the Treatment of ANCA-Associated Vasculitis
    Matsuo, Yusuke
    Miyabe, Yoshishige
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21):
  • [10] Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan
    Aqeel, Faten
    Zonozi, Reza
    Jeyabalan, Anushya
    Sauvage, Gabriel
    Niles, John L.
    Geetha, Duvuru
    RMD OPEN, 2023, 9 (03):
12345